HLA-G and IL-10 expression in human cancer--different stories with the same message.

Abstract excerpt

Immune evasion in cancer may result from structural and functional alterations of human leukocyte antigen (HLA) class I molecules and/or local release of immunosuppressive cytokines, such as interleukin (IL)-10. In lung cancer, both of these mechanisms seem to often take place, resulting in the impaired tumor recognition and the progression of the disease. In primary cutaneous lymphomas on the other side, the...

Topics

Share this publication in a Topic to start or enrich a Post.

• Share to Disease Progression
• Share to Histocompatibility Antigens Class I
• Share to HLA Antigens